New Eye Implant Clears Cloudy Vision
Get the world’s most fascinating discoveries delivered straight to your inbox.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered Daily
Daily Newsletter
Sign up for the latest discoveries, groundbreaking research and fascinating breakthroughs that impact you and the wider world direct to your inbox.
Once a week
Life's Little Mysteries
Feed your curiosity with an exclusive mystery every week, solved with science and delivered direct to your inbox before it's seen anywhere else.
Once a week
How It Works
Sign up to our free science & technology newsletter for your weekly fix of fascinating articles, quick quizzes, amazing images, and more
Delivered daily
Space.com Newsletter
Breaking space news, the latest updates on rocket launches, skywatching events and more!
Once a month
Watch This Space
Sign up to our monthly entertainment newsletter to keep up with all our coverage of the latest sci-fi and space movies, tv shows, games and books.
Once a week
Night Sky This Week
Discover this week's must-see night sky events, moon phases, and stunning astrophotos. Sign up for our skywatching newsletter and explore the universe with us!
Join the club
Get full access to premium articles, exclusive features and a growing list of member rewards.
A new type of cornea implant could restore some vision in infants and children who are blind due to a cloudy or damaged cornea, a study has found.
The cornea is a typically clear covering of the eye that serves as our window to the world. But in some children, conditions like glaucoma, infections and vitamin A deficiency can cloud the cornea as if an opaque curtain has been pulled over that window.
Corneal blindness is the world’s fourth leading cause of blindness, following cataract, glaucoma and age-related macular degeneration, according to the World Health Organization.
While natural corneas from donors are the main source for transplants, such tissue can trigger rejection by the immune system as well as scarring from infections or out-of-control blood vessel growth. In the United States, approximately 20 percent of corneal transplant patients—between 6,000 and 8,000 a year—reject their donor corneas, according to the National Eye Institute.
The contact-lens-sized implant is made of plastic and is sewn into the patient's eyeball with a piece of donor tissue. Physicians at the University of Rochester Eye Institute and Johns Hopkins University performed the implant operations on 17 children, aged six weeks to 13 years old. Together, the children had racked up 39 traditional failed cornea transplants.
Two of the children received another type of artificial implant that failed, while 15 received the “K-Pro” device. All 15 of those children recovered some vision, sometimes remarkably so, and none had an infection. In the seven cases where the child was at least 4 years old and could describe results, each could at least see fingers held at arm's length.
""Thirty years ago, our hope was that after the operation, patients could see well enough to see some movement and care for themselves for a few years. That was considered success,” said James Aquavella of the University of Rochester, who operated on the children. “Now many of our patients are out driving cars, riding horses, and leading active lives, and several have near-normal vision soon after the operation."
Get the world’s most fascinating discoveries delivered straight to your inbox.
Corneal transplants have been trickiest in children, whose immune systems are relatively vigorous and can mount more powerful attacks against foreign tissue than adults. For the best results, children must receive the implant before their vision is permanently shot, doctors say.
"If the brain has been deprived of vision at an early age, it's permanently affected, no matter how well the eye is focused later on. That's why it's crucial to intervene early on,” said one of the doctors involved in the operations, Matthew Gearinger of the Eye Institute.
- Why Eyes are So Alluring
- How the Human Eye Works
- Top 10 Mysterious Diseases
- Body Quiz 3: What the Parts Do
Jeanna Bryner is managing editor of Scientific American. Previously she was editor in chief of Live Science and, prior to that, an editor at Scholastic's Science World magazine. Bryner has an English degree from Salisbury University, a master's degree in biogeochemistry and environmental sciences from the University of Maryland and a graduate science journalism degree from New York University. She has worked as a biologist in Florida, where she monitored wetlands and did field surveys for endangered species, including the gorgeous Florida Scrub Jay. She also received an ocean sciences journalism fellowship from the Woods Hole Oceanographic Institution. She is a firm believer that science is for everyone and that just about everything can be viewed through the lens of science.
